Brooke Sadler1, Timothy Kuensting1, Jennifer Strahle2, Tae Sung Park2, Matthew Smyth2, David D Limbrick2, Matthew B Dobbs3, Gabe Haller2, Christina A Gurnett4. 1. Department of Neurology, Washington University in St. Louis, St Louis, Missouri. 2. Department of Neurosurgery, Washington University in St. Louis, St. Louis, Missouri. 3. Department of Orthopedic Surgery, Washington University in St. Louis, St. Louis, Missouri. 4. Department of Neurology, Washington University in St. Louis, St Louis, Missouri. Electronic address: gurnettc@wustl.edu.
Abstract
BACKGROUND: Chiari malformation type 1 affects approximately one in 1,000 people symptomatically, although one in 100 meet radiological criteria, making it a common neurological disorder. The diagnosis of underlying conditions has become more sophisticated, and new radiological markers of disease have been described. We sought to determine the prevalence and impact of additional comorbidities and underlying diagnoses in patients with Chiari malformation type 1 on symptomatology and surgical treatment. METHODS: A retrospective review of 612 pediatric patients with a Chiari malformation type 1 diagnosis and imaging data evaluated between 2008 and 2018 was performed. Because of extensive clinical heterogeneity, patients were separated into four categories based on their primary comorbidities (nonsyndromic, central nervous system, skeletal, and multiple congenital anomalies) to identify associations with age of onset, radiographic measurements, syringomyelia, and surgical treatment. RESULTS: The largest group had nonsyndromic Chiari malformation type 1 (70%) and the latest age at diagnosis of any group. In the syndromic group, 6% were diagnosed with a known genetic abnormality, with overgrowth syndromes being the most common. Patients with multiple congenital anomalies had the earliest Chiari malformation type 1 onset, the most severe tonsillar ectopia and obex position, and were overrepresented among surgical cases. Although there were no statistically significant differences between groups and rates of syrinx, we observed differences in individual diagnoses. CONCLUSION: The underlying diagnoses and presence of comorbidities in patients with Chiari malformation type 1 impacts rates of syringomyelia and surgery. Although most Chiari malformation type 1 cases are nonsyndromic, clinical evaluation of growth parameters, scoliosis, and joint hypermobility should be routine for all patients as they are useful to determine syringomyelia risk and may impact treatment.
BACKGROUND: Chiari malformation type 1 affects approximately one in 1,000 people symptomatically, although one in 100 meet radiological criteria, making it a common neurological disorder. The diagnosis of underlying conditions has become more sophisticated, and new radiological markers of disease have been described. We sought to determine the prevalence and impact of additional comorbidities and underlying diagnoses in patients with Chiari malformation type 1 on symptomatology and surgical treatment. METHODS: A retrospective review of 612 pediatric patients with a Chiari malformation type 1 diagnosis and imaging data evaluated between 2008 and 2018 was performed. Because of extensive clinical heterogeneity, patients were separated into four categories based on their primary comorbidities (nonsyndromic, central nervous system, skeletal, and multiple congenital anomalies) to identify associations with age of onset, radiographic measurements, syringomyelia, and surgical treatment. RESULTS: The largest group had nonsyndromic Chiari malformation type 1 (70%) and the latest age at diagnosis of any group. In the syndromic group, 6% were diagnosed with a known genetic abnormality, with overgrowth syndromes being the most common. Patients with multiple congenital anomalies had the earliest Chiari malformation type 1 onset, the most severe tonsillar ectopia and obex position, and were overrepresented among surgical cases. Although there were no statistically significant differences between groups and rates of syrinx, we observed differences in individual diagnoses. CONCLUSION: The underlying diagnoses and presence of comorbidities in patients with Chiari malformation type 1 impacts rates of syringomyelia and surgery. Although most Chiari malformation type 1 cases are nonsyndromic, clinical evaluation of growth parameters, scoliosis, and joint hypermobility should be routine for all patients as they are useful to determine syringomyelia risk and may impact treatment.
Authors: Justin Wang; Naif M Alotaibi; Nardin Samuel; George M Ibrahim; Aria Fallah; Michael D Cusimano Journal: World Neurosurg Date: 2016-11-25 Impact factor: 2.104
Authors: Neera Nathan; Kim M Keppler-Noreuil; Leslie G Biesecker; Joel Moss; Thomas N Darling Journal: Dermatol Clin Date: 2017-01 Impact factor: 3.478
Authors: Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto Journal: Am J Med Genet C Semin Med Genet Date: 2016-11-18 Impact factor: 3.908
Authors: Samantha R Horn; Nicholas Shepard; Dennis Vasquez-Montes; Cole A Bortz; Frank A Segreto; Rafael De La Garza Ramos; C Rory Goodwin; Peter G Passias Journal: J Clin Neurosci Date: 2018-09-29 Impact factor: 1.961
Authors: Christina A Markunas; Eric Lock; Karen Soldano; Heidi Cope; Chien-Kuang C Ding; David S Enterline; Gerald Grant; Herbert Fuchs; Allison E Ashley-Koch; Simon G Gregory Journal: BMC Med Genomics Date: 2014-06-25 Impact factor: 3.063
Authors: Blaise Simplice Talla Nwotchouang; Alaaddin Ibrahimy; Dorothy M Loth; Edward Labuda; Nicholas Labuda; Maggie Eppleheimer; Richard Labuda; Jayapalli Rajiv Bapuraj; Philip A Allen; Petra Klinge; Francis Loth Journal: Neuroradiology Date: 2021-07-11 Impact factor: 2.995